$Ultra Nasdaq Biotechnology Proshares(BIB.US)$was climbing 1.5%. $SciSparc(SPRC.US)$rallied Wednesday, climbing over 20%, after the Israeli pharmaceuticals company said the psychedelic-based MEAI drug candidate developed with Canadian collaborator Clearmind Medicine produced a significant decrease in coccaine craving in rats compared to those in a non-treated control group during pre-clinical testing. $Glaukos(GKOS.US)$gained 6% after We...